Results 151 to 160 of about 28,403 (261)

Changes in plasma hydrogen sulfide are associated with cognitive improvements in schizophrenia patients treated with atypical antipsychotics. [PDF]

Front Psychiatry
Huang YC, Li YH, Li L, Xiong JW, Wei B, Yang YJ, Zhao Y, Zhan HY.   +7 more
europepmc   +1 more source

Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
This graphical abstract illustrates a case of Prader–Willi syndrome with compulsive scratching behavior, in which augmentation with lurasidone following vortioxetine treatment resulted in marked symptom improvement. The case highlights a potential pharmacological approach for obsessive‐compulsive–related behaviors in Prader–Willi syndrome.
Yasuhide Nagoshi
wiley   +1 more source

Association of Preoperative Depression and Clinical Outcomes After Head and Neck Free Flap Reconstruction

Otolaryngology–Head and Neck Surgery, Volume 174, Issue 6, Page 1476-1483, June 2026.
Abstract Objective Comorbid depression is a significant negative predictor of survival in patients with head and neck cancer (HNC). Prior studies have shown a prevalence of up to 40.1%; however, depression is often underdiagnosed in this patient population. Study Design Retrospective cohort. Setting Single‐institution database.
Sindhura Sridhar, Daniel P. Larson, Brooke B. Swain, Heezy Suh, Daniel R. S. Habib, Kelly Vittetoe, Donald Sengstack, Michael C. Topf, Melanie D. Hicks   +8 more
wiley   +1 more source

Clozapine‐induced diarrhea: A case report and mechanistic overview

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Clozapine is an atypical antipsychotic that is highly effective in managing treatment‐resistant schizophrenia. However, its use is associated with a wide range of adverse effects, including agranulocytosis, seizures, sedation, and gastrointestinal issues such as constipation, and less commonly, diarrhea. While constipation is a well‐
Shahab Dastmardi, Soha Namazi
wiley   +1 more source

Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS). [PDF]

Alpha Psychiatry
Zhao X, Cheng Y, He S, Mou F, Li W, Yu S.   +5 more
europepmc   +1 more source

A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics. [PDF]

Neuropsychiatr Dis Treat, 2023
Wang L, Chen X, Gu X, Gu X, De Smedt H, Popova V, Fu DJ, Canuso CM, Drevets WC, Chen G.   +9 more
europepmc   +1 more source

Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
This graphical summary illustrates the efficacy and safety of brexpiprazole (2–4 mg) in patients with schizophrenia. The meta‐analysis demonstrates significant improvement in clinical outcomes, with reductions in Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression ‐ Severity scale (CGI‐S) scores, indicating better symptom ...
Sher Bano, Aashan Ahmad, Abdul Haseeb Mohammed, Ismailova Rushana Nurbekovna, Saja Saad, Noor Fatima, Muhammad Bilal Akbar, Zainab Salahuddin, Sadikun Nabi, Mohammad Mustafa Ababneh, Laiba Ajmal, Sidra Hariss, Hiba Manaf, Farah Saleh, Raouf Khan   +14 more
wiley   +1 more source

Clinical evaluation of Dachai Wendan Decoction in the treatment of metabolic syndrome induced by atypical antipsychotics: A retrospective study. [PDF]

Medicine (Baltimore)
Wu Y, Zhao X, Cui J, Lv M, Hu B, Xu C, Zheng J, Yang F, Yan S.   +8 more
europepmc   +1 more source

Atypical Antipsychotics and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis. [PDF]

Gen Hosp Psychiatry, 2023
Nash RP, Wang L, Gaynes BN, Flythe JE.
europepmc   +1 more source

CAT‐Hokkaido: A tablet‐based assessment of cognitive impairment in schizophrenia

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
CAT‐Hokkaido is a brief tablet‐based cognitive assessment covering six neurocognitive domains relevant to schizophrenia. In patients with schizophrenia, it detected deficits in four of six tasks and showed significant correlations with corresponding MCCB measures, supporting its potential utility in assessing cognitive impairment.
Atsuhito Toyomaki, Hayato Watanabe, Ryo Sawagashira, Chiemi Kubota, Naoki Hashimoto, Takahiro A. Kato   +5 more
wiley   +1 more source